Partners
Past & Present

Ansaris has had discovery collaborations with a broad group of international pharmaceutical and biotechnology partners on projects ranging from computational de novo drug design, to hit-to-lead, and hit-to-preclinical candidate. Ansaris' current partners are Ono Pharmaceuticals (Japan) and Novartis.